Journal
CHEMISTRY & BIOLOGY
Volume 16, Issue 6, Pages 657-666Publisher
CELL PRESS
DOI: 10.1016/j.chembiol.2009.04.012
Keywords
-
Categories
Funding
- ANR [ANR-06-PCVI-0024]
- Agence Nationale de la Recherche (ANR) [ANR-06-PCVI-0024] Funding Source: Agence Nationale de la Recherche (ANR)
Ask authors/readers for more resources
RhoGEFs (guanine nucleotide exchange factors of the Rho GTPase family) are upstream regulators of cell adhesion and migration pathways, thus representing attractive yet relatively unexplored targets for the development of anti-invasive drugs. We screened for chemical inhibitors of TrioN, the N-terminal GEF domain of the multidomain Trio protein, and identified ITX3 as a nontoxic inhibitor. In transfected mammalian cells, ITX3 blocked TrioN-mediated dorsal membrane ruffling and Rac1 activation while having no effect on GEF337-, Tiam1-, or Vav2-mediated RhoA or Rac1 activation. ITX3 specifically inhibited endogenous TrioN activity, as evidenced by its ability to inhibit neurite outgrowth in nerve growth factor (NGF)-stimulated PC12 cells or C2C12 differentiation into myotubes. This study introduces a selective cell active inhibitor of the Trio/RhoG/Rac1 pathway and validates RhoGEFs as druggable targets.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available